Updates
** Shares of medical device maker Kestra Medical Technologies KMTS.O open 35% above the offer price in their Nasdaq debut
** Stock opens at $22.95, compared to the $17 IPO price, giving the Kirkland, Washington-based company a $1.14 billion market cap
** KMTS, backed by buyout firm Bain Capital, sold about 11.9 mln shares in its upsized offering, 19% more than initially offered, and above its marketed range of $14 to $16 apiece to raise $202 mln
** Listing marks first notable March IPO and third medical device maker flotation in New York since October
** KMTS competes in the wearable cardioverter defibrillator market, which has been dominated by Zoll Medical
** BofA Securities, Goldman Sachs and Piper Sandler were the lead bookrunners for the offering
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Comments